Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy

Abstract

Abstract Antiangiogenic agents, such as ramucirumab, should be cautiously administered along with radiotherapy because of the enhanced risk of adverse events.

Keywords

• antiangiogenic agent
• bone metastasis
• esophageal stenosis
• palliative radiotherapy
• ramucirumab